Saving
Sticking the critically ill with a hefty tab for expensive medications is enough to turn my stomach. But the practice may become widespread among health-insurance companies. Insurers are embracing new pricing plans for drugs that typically require patients to pay between 20% and 33% of certain high-price medications, according to a report by The New York Times. The plans often require that patients suffering from serious afflictions such as hepatitis C and cancer shell out thousands of dollars, instead of predetermined co-pay amounts. One such drug, Copaxone, developed by Teva PharmaceuticalTEVA in Israel, is a treatment option for multiple sclerosis patients. Why shortchange the seriously ill? Apparently, insurers want to keep premiums down. Requiring patients to fork over significant cash to treat a life-threatening illness, however, defeats the purpose of health insurance. Health insurance premiums for employers increased by 6.1% in 2007 -- two times the rate of inflation, according to the National Coalition on Healthcare, a Washington, D.C.-based nonprofit health-care advocacy group. The increase parallels the rise in national health expenditures, which were expected to rise 6.9% last year. It seems that many Americans -- and their employers -- pay more every year to reap less. Sure, there may be coverage for the more predictable medical expenses such as preventive care, childbirth and perhaps an appendectomy. The emerging trend in drug coverage, however, is disturbing evidence of diminishing coverage for Americans who need it most -- and who are, perhaps, the least capable of fighting back.
![]() |
How to not get burned by all the turmoil in the airline industry.
Hedge fund executive's misfortune holds a lesson for anyone dreaming of 15 minutes of fame.
Cutting things off sooner rather than later can save a bundle of money.
Yahoo! is among the most searched stocks on TheStreet.com. Here's what Cramer had to say about the stock recently.
Catch up on his thinking on the hottest topics of the past week.
Investors will have to deal with a Fed meeting and another flood of earnings and economic data.
Ensco International and Echelon have the potential to move higher in coming days.
See who made what calls.
The addition of video is helping telecom companies compete against cable and satellite companies.
The June West Texas Intermediate contract reflects selling pressure ahead of Tuesday's expiration. But stocks in the sector are generally trading higher.
See who made what calls.
Keep on top of the market and the critical information you need to make more profitable investing decisions.
Sponsored by:

ACCESS REALMONEY



